M

Max-Planck-Gesellschaft

Europe, Baden-Wurttemberg, Germany, Heidelberg

Description

Max-Planck-Gesellschaft Germany's fundamental , research and science organization.

Investor Profile

Max-Planck-Gesellschaft has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical Device.

Stage Focus

  • Series B (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Max-Planck-Gesellschaft frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
Santo Holding
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 1
MIG Capital
Europe, Bayern, Germany, München
Co-Investments: 1

What are some of recent deals done by Max-Planck-Gesellschaft?

SuppreMol

Martinsried, Bayern, Germany

SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.

BiotechnologyHealth CareMedical Device
Series BJul 15, 2008
Amount Raised: $24,979,595